Learn More About Osprey Medical (ASX: OSP)
Osprey Medical (ASX: OSP)
Reports Graph
1-System to reduce the amount of dye (contrast) injected during commonly performed heart procedures, thus protecting kidneys from damage known as contrast induced nephropathy (CIN) and 2-A percutaneous technology that allows physicians to deliver targeted doses of antibiotics to the lower limb in patients with diabetes suffering from advanced foot infections
Technology/product details
Potential acquirers
Revenue projections
Capital raised to date
Growth strategy
Market landscape
Competing Startups
More

Get a Demo and See the Full Profile

Get a demo today to see profiles of Spineology plus 6164 other startups.

Trusted By The Companies Pioneering What’s Next